I. Könyves

418 total citations
17 papers, 333 citations indexed

About

I. Könyves is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, I. Könyves has authored 17 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Genetics. Recurrent topics in I. Könyves's work include Cancer Treatment and Pharmacology (6 papers), Prostate Cancer Treatment and Research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). I. Könyves is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Prostate Cancer Treatment and Research (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). I. Könyves collaborates with scholars based in Sweden, Canada and United Kingdom. I. Könyves's co-authors include L. Brandt, Torgil R. Möller, Julie A. Kovacs, Lars‐Göran Lindberg, József Kovács, L. Andersson, Edward D. Gilby, Robert W. Wilkinson, G. Jönsson and F. Edsmyr and has published in prestigious journals such as The Journal of Organic Chemistry, Cellular and Molecular Life Sciences and Urology.

In The Last Decade

I. Könyves

17 papers receiving 281 citations

Peers

Countries citing papers authored by I. Könyves

Since Specialization

Citations

This map shows the geographic impact of I. Könyves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Könyves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Könyves more than expected).

Fields of papers citing papers by I. Könyves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Könyves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Könyves. The network helps show where I. Könyves may publish in the future.

Co-authorship network of co-authors of I. Könyves

This figure shows the co-authorship network connecting the top 25 collaborators of I. Könyves. A scholar is included among the top collaborators of I. Könyves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Könyves. I. Könyves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Estramustine phosphate (Estracyt®) in the treatment of prostatic carcinoma 1989 ·International Urology and Nephrology ·I. Könyves	7
2	International overview on the treatment of prostate cancer–scandinavian experience 1984 ·The Prostate ·I. Könyves, L. Andersson	2
3	Estramustine phosphate—historical overview 1984 ·Urology ·H. Fex, B. Högberg, I. Könyves	10
4	Chemotherapy principles in the treatment of prostatic cancer 1984 ·The Prostate ·I. Könyves, Jonas Müntzing, Marcel Rozencweig	10
5	Hormone cytostatic agents. 1980 ·PubMed ·I. Könyves	5
6	Phase II study of Leo 1031 (prednimustine) in advanced ovarian carcinoma. 1979 ·PubMed ·J. E. Johnsson, Claes G. Tropé, W. Mattsson, Hans Grundsell, Knut Aspegren, I. Könyves	16
7	Continuous Treatment of Non-Hodgkin’s Malignant Lymphoma with Prednimustine (Leo 1031) 1978 ·Oncology ·Leif Håkansson, I. Könyves, Lars‐Göran Lindberg, Henrik Møller	16
8	Therapeutic effect of prednimustine (LEO 1031) in various types of leukaemia 1977 ·European Journal of Cancer (1965) ·L. Brandt, I. Könyves	17
9	Studies on the toxicity and antitumour activity of prednimustine, a prednisolone ester of chlorambucil 1977 ·European Journal of Cancer (1965) ·Kenneth R. Harrap, P G Riches, Edward D. Gilby, (unknown), Robert W. Wilkinson, I. Könyves	37
10	Estramustine Phosphate Therapy in Carcinoma of the Prostate 1977 ·Recent results in cancer research ·L. Andersson, F. Edsmyr, G. Jönsson, I. Könyves	24
11	Preliminary clinical and absorption studies with prednimustine in patients with mammary carcinoma 1975 ·European Journal of Cancer (1965) ·I. Könyves, Bo Nordenskjöld, Gustaf Plym Forshell, A. De Schryver, (unknown)	26
12	THERAPEUTIC EFFECT OF LEO 1031, AN ALKYLATING CORTICOSTEROID ESTER, IN LYMPHOPROLIFERATIVE DISORDERS 1975 ·Acta Medica Scandinavica ·Torgil R. Möller, L. Brandt, I. Könyves, Lars‐Göran Lindberg	25
13	THERAPEUTIC EFFECT OF LEO 1031, AN ALKYLATING CORTICOSTEROID ESTER, IN LYMPHOPROLIFERATIVE DISORDERS 1975 ·Acta Medica Scandinavica ·L. Brandt, I. Könyves, Torgil R. Möller	34
14	Estracyt in hormone-resistant prostatic carcinoma 1974 ·International Urology and Nephrology ·(unknown), I. Könyves, (unknown), S. Eckhardt, (unknown)	6
15	Some Nitrated Derivatives of Estriol. 1964 ·Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry ·I. Könyves, (unknown), J. A. Elvidge, J. S. Burton, Roger Stevens	3
16	Chemical Studies of Polyaspartic Acids¹ 1961 ·The Journal of Organic Chemistry ·József Kovács, (unknown), I. Könyves, (unknown), (unknown), (unknown)	59
17	Darstellung von Polyasparaginsäuren (Polyaspartsäuren) aus dem thermischen Autokondensationsprodukt der Asparaginsäure 1953 ·Cellular and Molecular Life Sciences ·Julie A. Kovacs, I. Könyves, (unknown)	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact